Max Other Stockholder Equity from 2010 to 2024

MAXHEALTH   1,019  39.45  4.03%   
Max Healthcare Other Stockholder Equity yearly trend continues to be quite stable with very little volatility. The value of Other Stockholder Equity is projected to decrease to about 28.5 B. From the period between 2010 and 2024, Max Healthcare, Other Stockholder Equity regression line of its data series had standard deviation of  19,677,581,933 and standard deviation of  19,677,581,933. View All Fundamentals
 
Other Stockholder Equity  
First Reported
2010-12-31
Previous Quarter
51.8 B
Current Value
28.5 B
Quarterly Volatility
19.7 B
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Max Healthcare financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Max Healthcare's main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.4 B, Interest Expense of 954.1 M or Selling And Marketing Expenses of 3.9 B, as well as many indicators such as . Max financial statements analysis is a perfect complement when working with Max Healthcare Valuation or Volatility modules.
  
This module can also supplement various Max Healthcare Technical models . Check out the analysis of Max Healthcare Correlation against competitors.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Max Stock

Max Healthcare financial ratios help investors to determine whether Max Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Max with respect to the benefits of owning Max Healthcare security.